• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用电子健康记录的自动实时经皮冠状动脉介入治疗风险模型

Automated Real-Time Percutaneous Coronary Intervention Risk Model Leveraging Electronic Health Records.

作者信息

Singh Mandeep, Arruda-Olson Adelaide M, Lewis Bradley R, Johnson Bradley K, Chaudhry Rajeev, Arghami Arman, Alkhouli Mohamad, Rihal Charanjit S

机构信息

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

JACC Adv. 2025 Jun 25;4(7):101865. doi: 10.1016/j.jacadv.2025.101865.

DOI:10.1016/j.jacadv.2025.101865
PMID:40570609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12246847/
Abstract

BACKGROUND

Automated individualized risk prediction tools linked to electronic health records (EHRs) are not available for patients undergoing percutaneous coronary interventions (PCIs).

OBJECTIVES

Our goal was to automatically extract data elements used in the Mayo Clinic PCI models from EHR to enable point of care risk assessment.

METHODS

Using the Mayo Clinic PCI registry, variables in the Mayo Clinic PCI risk score were trained and tested in an EHR to identify in-hospital death, stroke, bleeding, acute kidney injury (AKI) in patients who underwent PCI from 2016 to 2024. Least absolute shrinkage and selection operator regression was utilized to train (data building) and test (assessing performance) prediction models and to estimate effect sizes that were weighted and integrated into a scoring system.

RESULTS

Death, stroke, bleeding, AKI occurred in 157 (1.8%), 43 (0.5%), 157 (1.8%), and 682 (7.6%), respectively. The C-statistics (95% CI) from the training and testing data sets were 0.83 (95% CI: 0.80-0.86) and 0.84 (95% CI: 0.78-0.89); 0.76 (95% CI: 0.65-0.84) and 0.77 (95% CI: 0.65-0.86); 0.80 (95% CI: 0.75-0.83) and 0.75 (95% CI: 0.68-0.81); and 0.82 (95% CI: 0.80-0.84) and 0.80 (95% CI: 0.77-0.84) for in-hospital death, stroke, bleeding, and AKI, respectively. Bootstrap analysis indicated that the models were not overfit to the available data set. The probabilities estimated from the models matched the observed data well, as indicated by the calibration curve slope and intercept and across subgroups, including women, acute coronary syndrome, cardiogenic shock, and diabetes mellitus.

CONCLUSIONS

Real-time, automated, point of care PCI risk assessment is feasible in an EHR environment.

摘要

背景

对于接受经皮冠状动脉介入治疗(PCI)的患者,尚无与电子健康记录(EHR)相关联的自动化个体化风险预测工具。

目的

我们的目标是从电子健康记录中自动提取梅奥诊所PCI模型中使用的数据元素,以实现即时护理风险评估。

方法

利用梅奥诊所PCI登记处的数据,在电子健康记录中对梅奥诊所PCI风险评分中的变量进行训练和测试,以识别2016年至2024年接受PCI治疗患者的院内死亡、中风、出血、急性肾损伤(AKI)情况。采用最小绝对收缩和选择算子回归来训练(数据构建)和测试(评估性能)预测模型,并估计效应大小,将其加权并整合到评分系统中。

结果

死亡、中风、出血、AKI的发生例数分别为157例(1.8%)、43例(0.5%)、157例(1.8%)和682例(7.6%)。训练数据集和测试数据集的C统计量(95%CI)分别为:院内死亡为0.83(95%CI:0.80 - 0.86)和0.84(95%CI:0.78 - 0.89);中风为0.76(95%CI:0.65 - 0.84)和0.77(95%CI:0.65 - 0.86);出血为0.80(95%CI:0.75 - 0.83)和0.75(95%CI:0.68 - 0.81);AKI为0.82(95%CI:0.80 - 0.84)和0.80(95%CI:0.77 - 0.84)。自助法分析表明,模型对可用数据集没有过度拟合。校准曲线斜率和截距以及在包括女性、急性冠状动脉综合征、心源性休克和糖尿病等亚组中显示,模型估计的概率与观察数据匹配良好。

结论

在电子健康记录环境中,实时、自动化的即时护理PCI风险评估是可行的。

相似文献

1
Automated Real-Time Percutaneous Coronary Intervention Risk Model Leveraging Electronic Health Records.利用电子健康记录的自动实时经皮冠状动脉介入治疗风险模型
JACC Adv. 2025 Jun 25;4(7):101865. doi: 10.1016/j.jacadv.2025.101865.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.普拉格雷(Efient®)联合经皮冠状动脉介入治疗急性冠状动脉综合征(TA182综述):系统评价与经济学分析
Health Technol Assess. 2015 Apr;19(29):1-130. doi: 10.3310/hta19290.
4
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
5
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
6
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
7
Comparing the Performance of Machine Learning Models and Conventional Risk Scores for Predicting Major Adverse Cardiovascular Cerebrovascular Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: Systematic Review and Meta-Analysis.比较机器学习模型与传统风险评分对急性心肌梗死患者经皮冠状动脉介入治疗后主要不良心血管脑血管事件的预测性能:系统评价与荟萃分析
J Med Internet Res. 2025 Jul 18;27:e76215. doi: 10.2196/76215.
8
Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.急性心肌梗死直接血管成形术的临床疗效与成本效益:系统评价与经济学评估
Health Technol Assess. 2005 May;9(17):1-99, iii-iv. doi: 10.3310/hta9170.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.一项针对稳定型心绞痛的经皮冠状动脉介入治疗的安慰剂对照试验。
N Engl J Med. 2023 Dec 21;389(25):2319-2330. doi: 10.1056/NEJMoa2310610. Epub 2023 Nov 11.
2
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
3
Clinical Significance of Biological Age in Patients Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者生物学年龄的临床意义。
Mayo Clin Proc. 2023 Aug;98(8):1137-1152. doi: 10.1016/j.mayocp.2023.03.022.
4
Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem.经皮冠状动脉介入治疗中的风险预测:解决最后一公里问题。
Circ Cardiovasc Interv. 2022 Jul;15(7):e012262. doi: 10.1161/CIRCINTERVENTIONS.122.012262. Epub 2022 Jul 19.
5
Multimorbidity and Mortality Models to Predict Complications Following Percutaneous Coronary Interventions.多病症与死亡率模型预测经皮冠状动脉介入治疗后的并发症。
Circ Cardiovasc Interv. 2022 Jul;15(7):e011540. doi: 10.1161/CIRCINTERVENTIONS.121.011540. Epub 2022 Jul 19.
6
Coronary Risk Estimation Based on Clinical Data in Electronic Health Records.基于电子健康记录中的临床数据的冠状动脉风险估计。
J Am Coll Cardiol. 2022 Mar 29;79(12):1155-1166. doi: 10.1016/j.jacc.2022.01.021.
7
Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non-ST-Segment-Elevation Myocardial Infarction for Intensive Care Unit Admission.将预测分析集成到电子健康记录中,以筛选出非ST段抬高型心肌梗死的高风险稳定患者入住重症监护病房。
Circ Cardiovasc Qual Outcomes. 2021 Apr;14(4):e007602. doi: 10.1161/CIRCOUTCOMES.120.007602. Epub 2021 Mar 24.
8
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
9
Contrast-Associated Acute Kidney Injury.对比剂相关急性肾损伤
N Engl J Med. 2019 May 30;380(22):2146-2155. doi: 10.1056/NEJMra1805256.
10
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.定义经皮冠状动脉介入治疗患者的高出血风险:来自高出血风险学术研究联合会的共识文件。
Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.